<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1510246042
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1993
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        AMRIZOLE INJ 500MG-100ML BOTTLE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        METRONIDAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Intravenous use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        9.50
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 540]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            ZIMMO TRADING ESTABLISHMENT
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            ALAMRIAH FOR PHARMACEUTICALS INDUSTRIES
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        J01XD01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The name of this medicine is Amrizole 0.5% Injectable Solution for Infusion (called Amrizole in this leaflet).</p><p>Amrizole&nbsp; contains a medicine called metronidazole. This belongs to a group of medicines called antibiotics.</p><p>It works by killing the bacteria that cause infections in your body.</p><p>It can be used to:</p><p>Treat infections of the blood, brain, lung, bones, genital tract, pelvic area and stomach</p><p>Prevent infections after surgery</p><p>If you need any further information on your illness, speak to your doctor.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Do not have Amrizole if:</strong></p><p>You are allergic (hypersensitive) to metronidazole, nitroimidazoles (e.g. tinidazole) or any of the other ingredients in your medicine (listed in Section 6: Further information).</p><p>Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat or tongue.</p><p>Do not have Amrizole if any of the above apply to you.</p><p>If you are not sure, talk to your doctor or pharmacist before receiving your medicine.</p><p><strong>Take special care with Amrizole and check with your doctor before having your medicine if:</strong></p><p>You have or have ever had a liver problem.</p><p>You are having kidney dialysis (see section 3: &lsquo;People having Kidney dialysis&rsquo;)</p><p>You have a disease of the nervous system</p><p>If you are not sure if any of the above apply to you, talk to your doctor before receiving your medicine. Do this even if they have applied in the past.</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Taking other medicines</strong></p><p>Please tell your doctor if you are taking or have recently taken any other medicines. This includes medicines obtained without a prescription, including herbal medicines. This is because Amrizole can affect the way some other medicines work. Also, some other medicines can affect the way Amrizole works.</p><p>In particular tell your doctor if you are taking any of the following medicines:</p><p>Medicines used to thin the blood such as warfarin</p><p>Lithium for mental illness</p><p>Phenobarbital or phenytoin for epilepsy</p><p>5 fluorouracil for cancer</p><p>Busulfan for leukaemia (cancer of the blood cells)</p><p>Ciclosporin &ndash; to prevent the rejection of organs after transplant</p><p>Disulfiram for alcoholism</p><p>If you are not sure, talk to your doctor before receiving your medicine.</p><p><strong>Having Amrizole with food and drink</strong></p><p>Do not drink any alcohol while you are having Amrizole and for 48 hours after finishing your course. Drinking alcohol whilst you are being treated might cause unpleasant side effects, such as feeling sick (nausea), being sick (vomiting), stomach pain, hot flushes, very fast or uneven heartbeat (palpitations) and headache.</p><p><strong>Pregnancy and breast-feeding</strong></p><p>Tell your doctor before having Amrizole if:</p><p>You are pregnant, might become pregnant or think you may be pregnant. Amrizole should not be taken during pregnancy unless considered absolutely necessary.</p><p>You are breast-feeding. It is better not to use Amrizole if you are breast-feeding. This is because small amounts may pass into the mother&rsquo;s milk.</p><p><strong>Driving and using machines</strong></p><p>While taking Amrizole you may feel sleepy, dizzy, confused, see or hear things that are not there (hallucinations), have fits (convulsions) or temporary eyesight problems (such as blurred or double vision). If this happens, do not drive or use any machinery or tools.</p><p><strong>Tests</strong></p><p>Your doctor may wish to carry out some tests if you have been having this medicine for more than 10 days</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>How your medicine will be given</strong></p><p>Your medicine will be administered to you by a doctor or nurse. The length of your course of treatment will depend on your needs and the illness being treated.</p><p>Amrizole is administered into a vein using a drip at a rate of 5ml/minute</p><p>Other antibiotics can be administered to help treat your infection.</p><p>The dose of Amrizole will depend on your needs and the illness being treated</p><p>The length of your treatment will depend on the type of infection you have and how bad it is</p><p>As soon as possible after starting your treatment with Amrizole, your doctor will suggest changing to a medicine taken by mouth</p><p>The usual dose for adults and children is given below:</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>To treat bacterial infection</strong></p><p><strong>Adults</strong></p><p>You will be given 500mg (100ml) Amrizole every 8 hours</p><p><strong>Children</strong></p><p>Your doctor will work out how much your child should be given depending on their weight</p><p>The dose will be repeated every 8 hours</p><p>If your child is a baby under 8 weeks of age, your doctor will give them one daily dose or two separate doses 12 hourly.</p><p><strong>To prevent infections from happening after surgery</strong></p><p><strong>Adults</strong></p><p>You will be given 500mg (100ml) Amrizole shortly before your Operation.&nbsp; The dose will be repeated every 8 hours</p><p><strong>Children</strong></p><p>Your doctor will work out how much your child should be given depending on their weight</p><p>Your child will receive the first dose 1-2 hours before their operation</p><p><strong>People having kidney dialysis</strong></p><p>Kidney dialysis removes Amrizole from your blood. If you are having kidney dialysis you must have this medicine after your dialysis treatment.</p><p><strong>People with liver problems</strong></p><p>Your doctor may lower your dose or use the medicine less often.</p><p><strong>If you are given more Amrizole than you should</strong></p><p>It is unlikely that your doctor or nurse will give you too much medicine. Your doctor or nurse will monitor your progress and check how much medicine you are given. Always ask if you are not sure why you are being given a medicine.</p><p><strong>If you are not given Amrizole at the right time</strong></p><p>If you do not receive your dose at the right time tell your doctor or nurse as soon as possible to arrange for another injection.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Amrizole can cause side effects, although not everybody gets them.</p><p><strong>Tell a doctor straight away if:</strong></p><p>You get swelling of the hands, feet, ankles, face, lips or throat which may cause difficulty in swallowing or breathing. You could also notice an itchy, lumpy rash (hives) or nettle rash (urticaria)</p><p>This may mean you are having an allergic reaction to Amrizole.</p><p>You get a high fever, headache, see or hear things that are not there, feel clumsy or have difficulty in controlling your movements, are confused, more sensitive to light than usual, notice a stiff neck, unusual behavior or eye movements or have problems with speaking. This could be a serious but very rare condition called encephalopathy</p><p><strong>Talk to your doctor straight away if you notice the following side effects.</strong></p><p>Yellowing of the skin and eyes. This could be due to a liver problem (jaundice).</p><p>Unexpected infections, mouth ulcers, bruising, bleeding gums, or severe tiredness. This could be caused by a blood problem.</p><p>Severe stomach pain which may reach through to your back (pancreatitis)</p><p>&nbsp;</p><p><strong>&nbsp;</strong></p><p><strong>Tell your doctor or nurse if you notice any of the following side effects:</strong></p><p><strong>Very rare (affects less than 1 in 10 000 people)</strong></p><p>Fits (convulsions)</p><p>Mental problems such as feeling confused and seeing or hearing things that are not there (hallucinations)</p><p>Problems with your eyesight such as blurred or double vision</p><p>Skin rash or flushing</p><p>Headache</p><p>Darkening of the urine</p><p>Feeling sleepy or dizzy</p><p>Pains in the muscles or joints</p><p><strong>Not known (frequency cannot be estimated from the available data)</strong></p><p>Numbness, tingling, pain, or a feeling of weakness, in the arms or legs</p><p>Unpleasant taste in the mouth</p><p>Furred tongue</p><p>Feeling sick (nausea), being sick (vomiting), upset stomach, stomach pains, or diarrhoea</p><p>Loss of appetite</p><p>Fever</p><p>Feeling depressed</p><p>Pain in your eyes (optic neuritis)</p><p>A group of symptoms together including: fever, nausea, vomiting, headache, stiff neck and extreme sensitivity to bright light. This may be caused by an inflammation of the membranes that cover the brain and spinal cord (meningitis)</p><p>If any of the side effects gets serious, lasts longer than a few days or you notice any side effects not listed in this leaflet, please tell your doctor or nurse</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The doctor and hospital pharmacist are usually responsible for storing, using and disposing of Amrizole correctly.</p><p>Keep this medicine in a safe place out of the reach and sight of children.</p><p>Do not use this medicine after the expiry date shown on the label.</p><p>Store this medicine below 30&ordm;C, protect from light</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Amrizole 0.5% Injectable Solution contains</p><p>&bull; The active ingredient is Metronidazole.</p><p>&bull; The other ingredients are: Sodium phosphate dihydrate, Citric acid monohydrate, Sodium chloride, Water for injection</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                A clear, bright, colourless to pale yellow sterile solution.
It comes in a carton box containing a glass vial of 100 ml Injectable solution

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Amriya Pharmaceutical Industries</p><p>Amriya , Km 25 Alexandria-Cairo desert road,</p><p>Alexandria-Egypt</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was last revised in September 2013.
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">اسم هذا الدواء هو أمريزول محلول للتنقيط الوريدى.</p><p dir="RTL">يحتوي هذا الدواء علي مترونيدازول والذي يتبع مجموعة الأدوية المسماة بمضادات البكتريا، وهو يعمل عن طريق قتل البكتيريا التي تسبب الالتهابات في الجسم.</p><p dir="RTL">ويمكن استخدامه فى:</p><p dir="RTL">&bull; علاج التهابات الدم، الدماغ،الرئة،العظام،المسالك التناسلية، ومنطقة الحوض والمعدة</p><p dir="RTL">&bull; منع العدوى بعد العمليات الجراحية</p><p>إذا كنت بحاجة إلى أي معلومات أخرى عن مرضك، يمكنك التحدث مع الطبيب</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>. قبل ان تتناول امريزول محلول للتنقيط الوريدى</strong></p><p dir="RTL"><strong>يجب ألا تستخدم أمريزول إذا</strong></p><p dir="RTL">إذا كانت لديك حساسية زائدة للمترونيدازول، نيترونايتروميدوزولات مثل تينيدازول أو أي من مكونات الدواء.</p><p dir="RTL">إذا ظهرت علامات حساسية وتشمل طفح جلدي، مشاكل فى البلع أو التنفس ، تورم الشفاه، الوجه، الحلق أو اللسان .</p><p dir="RTL">لا تستخدم أمريزول إذا كان أي من أعلاه ينطبق عليك . فى حالة عدم التأكد ، يرجى استشارة الطبيب أو الصيدلي قبل الاستخدام.</p><p dir="RTL"><strong>يجب توخي الحذر الزائد عند تناول المترونيدازول ومراجعة الطبيب أو الصيدلى قبل استخدام أمريزول إذا:</strong></p><p dir="RTL">كنت تعانى أو عانيت من قبل من مشاكل بالكبد</p><p dir="RTL">كنت تقوم بعملية غسيل كلوى</p><p dir="RTL">كنت تعانى أمراض الجهاز العصبى</p><p dir="RTL">إذا لم تكن متأكدا أن أيا مما ذكر ينطبق عليك، فيجب ابلاغ الطبيب أو الصيدلي قبل استخدام الدواء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>تناول الأدوية الأخري:</strong></p><p dir="RTL">يجب ابلاغ الطبيب او الصيدلي إذا تناولت أي أدوية حديثا وتشمل الأدوية التي تصرفها دون وصفة طبية وكذلك أدوية الأعشاب، لاحتمال حدوث تأثير للأمريزول علي طريقة عمل هذه الأدوية. كما أن بعض هذه الأدوية قد تؤثر علي طريقة عمل الأمريزول.</p><p dir="RTL">بشكل محدد، يجب ابلاغ الطبيب إذا كنت تتناول أي من الآتي:</p><p dir="RTL">الوارفارين - المتسخدم لتقليل لزوجة الدم.</p><p dir="RTL">الليثيوم &ndash; المتسخدم لعلاج الاكتئاب</p><p dir="RTL">الفينوباربيتال أو فينيتوين -&nbsp; المتسخدم لعلاج الصرع</p><p dir="RTL">5-فلورويوراسيل &ndash; المتسخدم لعلاج السرطان</p><p dir="RTL">بوسلفان &ndash; المتسخدم لعلاج سرطان خلايا الدم</p><p dir="RTL">سيكلوسبورين &ndash; المتسخدم بعد عمليات زراعة الأعضاء</p><p dir="RTL">ديسالفرام -&nbsp; لعلاج إدمان الكحول</p><p dir="RTL">فى حالة عدم التأكد، يجب ابلاغ الطبيب أو الصيدلي قبل استخدام الدواء.</p><p dir="RTL"><strong>تناول أمريزول مع الطعام والشراب</strong></p><p dir="RTL">يجب عدم تناول الكحوليات أثناء تعاطي المترونيدازول ولمدة 48 ساعة بعد انتهاء العلاج.&nbsp; قد تسبب الكحوليات ظهور أعراض جانبية غير مرغوب فيها مثل الغثيان، القيئ، ألم في أو حول البطن، توهج، زيادة ضربات القلب و صداع.</p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">يجب استشارة الطبيب قبل استخدام هذا الدواء إذا:</p><p dir="RTL">كنت حامل أو تعتقدين انك حامل أو قد تصبحين حامل، يجب عدم استخدام أمريزول أثناء الحمل إلا فى حالات الضرورة القصوى.</p><p dir="RTL">كنت فى فترة الرضاعة، يُفضل عدم استخدام أمريزول أثناء الرضاعة، لأن كمية صغيرة من الدواء قد تُفرز فى لبن الأم.</p><p dir="RTL"><strong>القيادة وتشغيل الماكينات</strong></p><p dir="RTL">قد يسبب أمريزول شعورا بالدوار، الدوخة أو الارتباك.&nbsp; كما قد يؤدي الي بعض الهلاوس السمعية والبصرية ، وقد تحدث تشنجات، زغللة أو ازدواج رؤية بالعين. إذا شعرت بأي من ذلك فينبغي عدم القيادة أو تشغيل الماكينات.</p><p dir="RTL"><strong>اختبارات </strong></p><p dir="RTL">قد يطلب منك الطبيب اجراء بعض الاختبارات، إذا كنت تناولت الدواء لفترة أكثر من 10 أيام.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف سيتم اعطاؤك الدواء</strong></p><p dir="RTL">سوف يقوم الطبيب أو الممرض بإعطائك الدواء. فترة العلاج سوف يتم تحديدها بناء على حالتك ونوع المرض الذى يتم علاجه.</p><p dir="RTL">يتم اعطاء&nbsp; أمريزول فى الوريد عن طريق جهاز منظم يقوم بتنقيط الحلول بمعدل 5ملل/ دقيقة.</p><p dir="RTL">قد يتم اعطائك مضادات حيوية أخرى لتساعد على علاجك.</p><p dir="RTL">تعتمد الجرعة على حالتك ونوع المرض الذى يتم علاجه.</p><p dir="RTL">تعتمد فترة العلاج على نوع العدوى المصاب بها وعلى مدى سوء الحالة الصحية.</p><p dir="RTL">بعد فترة معينة من استخدام الدواء، سوف يقوم الطبيب بتغير نوع العلاج من الحقن الى استخدام دواء يتم تناوله عن طريق الفم.</p><p dir="RTL">الجرعة المعتادة للبالغين والأطفال كمايلى:</p><p dir="RTL"><strong>لعلاج العدوى البكتيرية</strong></p><p dir="RTL"><strong>البالغين</strong></p><p dir="RTL">سوف يتم اعطائك 500مجم (100 ملل أمريزول) كل 8 ساعات.</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">سوف يحدد الطبيب الجرعة المناسبة لطفلك بناء على وزنه (عادة 7,5 مجم/كجم من وزن الجسم).</p><p dir="RTL">سوف يتم تكرار الجرعة كل 8 ساعات.</p><p dir="RTL"><strong>لمنع الإصابة بالعدوى بعد العمليات الجراحية</strong></p><p dir="RTL"><strong>البالغين</strong></p><p dir="RTL">سوف يتم اعطائك 500مجم (100 ملل أمريزول) قبل العملية بوقت قليل وأثناء وبعد انتهاء العملية.</p><p dir="RTL">سوف يتم تكرار الجرعة كل 8 ساعات.</p><p dir="RTL"><strong>الأطفال</strong></p><p dir="RTL">سوف يحدد الطبيب الجرعة المناسبة لطفلك بناء على وزنه (عادة 7,5 مجم/كجم من وزن الجسم).</p><p dir="RTL"><strong>المرضي الذين يقومون بغسيل الكلوى</strong></p><p dir="RTL">يتسبب الغسيل الكلوى بإزالة الأمريزول من الدم، لذلك إذا كنت تخضع للغسيل الكلوى، فعليك تناول&nbsp; الدواء بعد انتهاء عملية الغسيل الكلوى.</p><p dir="RTL"><strong>مرضي الكبد</strong></p><p dir="RTL">قد يصف لك الطبيب جرعات أقل من الجرعة الإعتيادية وذلك لاحتمال أن تكون أكثر حساسية للدواء.</p><p dir="RTL"><strong>في حالة استخدام جرعة&nbsp; من أمريزول أكبر من المفروض</strong></p><p dir="RTL">غير وارد أن يقوم الطبيب أو الممرض باعطائك كمية أكبر من الدواء. سوف يقوم الطبيب أو الممرض بمتابعة حالتك ومدى تحسنك&nbsp; وكمية الدواء التى يتم اعطائها لك. قم بسؤال الطبيب أو الممرض إذا كنت غير متأكد لماذا يتم منحك الدواء.</p><p dir="RTL"><strong>إذا لم يتم اعطائك الدواء فى الوقت المحدد</strong></p><p dir="RTL">إذا لم تتلقى الدواء فى الوقت المحدد، قم بإبلاغ الطبيب أو الممرض فوراً، حتى يتم اعطائك جرعة أخرى من الدواء</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الأعراض الجانبية الوارد حدوثها</strong></p><p dir="RTL">كما هو الحال مع كل الأدوية، فإن أمريزل قد يسبب أعراض جانبية الا انها قد لا تصيب كل من يتعاطي الدواء.</p><p dir="RTL"><strong>تحدث مع الطبيب فوراً فى حالة:</strong></p><p dir="RTL">حدوث انتفاخ وتورم فى اليدين، الأقدام، الكاحلين، الوجه، الشفتين، أو فى الحلق والذى قد يسبب صعوبة فى البلع والتنفس، قد تلاحظ أيضأً حدوث حكة أو طفح جلدى، وهذا يعنى أن لديك حساسية زائدة للأمريزول.</p><p dir="RTL">قد يحدث أيضاً حمى شديدة، صداع، رؤية أو سمع أشياء غير حقيقية، توهان أو صعوبة فى الحركة، شعور بالإضطراب، حساسية زائدة للضوء، تصلب فى الرقبة، حركة غير طبيعية فى العين، أو صعوبة فى التحدث.&nbsp; قد يكون هذا&nbsp; عرض جانبي خطير لكن نادر الحدوث وهو التهاب فى المخ<strong>.</strong></p><p dir="RTL"><strong>في حالة ظهور أي من الأعراض الجانبية الآتية، يجب استشارة الطبيب فوراً:</strong></p><p dir="RTL">اصفرار الجلد والعين (قد يكون ذلك ناتج عن مشاكل فى الكبد)</p><p dir="RTL">حدوث عدوى غير متوقعة، تقرحات فى الفم، كدمات، نزيف اللثة، أو الشعور بإرهاق شديد (قد يكون ذلك ناتج عن مشاكل فى الدم)</p><p dir="RTL">آلام شديدة فى المعدة قد تصل الى الظهر (قد يكون ذلك إلتهاب فى البنكرياس)</p><p dir="RTL"><strong>بلغ الطبيب أو الممرض فى حالة حدوث أى من الأعراض التالية:</strong></p><p dir="RTL"><strong>أعراض نادرة جداً (تحدث لأقل من 1 من كل 10000 شخص)</strong></p><p dir="RTL">تشنجات</p><p dir="RTL">مشاكل عقلية مثل الشعور بالإضطراب أو رؤية وسمع أشياء غير حقيقية (هلاوس)</p><p dir="RTL">اضطرابات فى الرؤية مثل الزغللة أو رؤية مزدوجة</p><p dir="RTL">طفح جلدى أو توهج</p><p dir="RTL">صداع</p><p dir="RTL">تغيير لون البول</p><p dir="RTL">الشعور بالنعاس أو الدوخة</p><p dir="RTL">ألم فى المفاصل والعضلات</p><p dir="RTL"><strong>أعراض جانبية قد تحدث بشكل غير متوقع</strong></p><p dir="RTL">تنميل، وخز، ألم أو الشعور بضعف الذراعين والأرجل</p><p dir="RTL">الشعور بطعم غير مستحب فى الفم</p><p dir="RTL">ألم وتورم الجلد أو طفح جلدي</p><p dir="RTL">لسان مفرى</p><p dir="RTL">الشعور بالغثيان أو القيىء أو ألم فى المعدة أو اسهال</p><p dir="RTL">فقدان الشهية</p><p dir="RTL">حمى</p><p dir="RTL">شعور بالإكتئاب</p><p dir="RTL">ألم فى العين</p><p dir="RTL">حدوث بعض الأعراض معاً وتشمل: حمى، غثيان، قيىء، صداع، تصلب الرقبة، وحساسية شديدة للضوء.&nbsp; قد يكون ذلك ناتج عن التهاب أغشية المخ والنخاع الشوكى.</p><p dir="RTL">إذا ازدادت أي من هذه الأعراض سوءا، أو استمرت لفترة طويلة، أو في حالة ظهور أعراض جانبية غير مذكورة بهذه النشرة يرجي ابلاغ الطبيب أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يخزن أمريزول محلول للتنقيط الوريدى</strong></p><p dir="RTL">حفظ واستخدام أمريزول بطريقة صحيحة، يكون عادة مسئولية الطبيب أو صيدلى المستشفى.</p><p dir="RTL">يجب حفظ الدواء بعيدا عن متناول أيدي الأطفال .</p><p dir="RTL">لا تستخدم الدواء بعد انتهاء تاريخ انتهاء الصلاحية المدون علي العبوة.</p><p dir="RTL">يحفظ في درجة حرارة أقل من30 &ordm;م، بعيداً عن الضوء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يحتوي أمريزول محلول للتنقيط الوريدى علي:</p><p dir="RTL">المادة الفعالة مترونيدازول</p><p dir="RTL">تشمل المواد الصواغ ما يلي: صوديوم فوسفات ثنائى المائية، حمض الستريك، كلوريد الصوديوم، ماء للحقن.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>كيف يبدو مستحضر أمريزول محلول للتنقيط الوريدى وشكل العبوة</strong></p><p dir="RTL">الدواء عبارة عن محلول معقم للتنقيط الوريدى عديم اللون يميل الى الأصفر الفاتح.</p><p dir="RTL">يأتي الدواء فى علبة تحتوى على فيال زجاجية بها 100 ملل محلول للحقن الوريدى.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">العامرية للصناعات الدوائية</p><p dir="RTL">العامرية، كم 25 طريق الاسكندرية &ndash; القاهرة الصحراوي</p><p dir="RTL">الاسكندرية &ndash; ج.م.ع.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            آخر مراجعة للنشرة سبتمبر 2013.
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amrizole 0.5% Injectable Solution
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                1 ml solution for infusion contains: 500 mg Metronidazole
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Solution in vial for intravenous infusion.
A clear, bright, colorless to pale yellow solution
The pH-value of the solution for infusion ranges from 4.5 to 6
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>:Metronidazole 500mg/100ml Intravenous Infusion is indicated in adults and children when oral medication is not possible for the following indications</p><p>&nbsp;</p><p>The prophylaxis of postoperative infections due to sensitive anaerobic bacteria particularly species of Bacteroides and anaerobic Streptococci, during abdominal, gynaecological gastrointestinal or colorectal surgery which carries a high risk of occurrence of this type of infection. The solution may also be used in combination with an antibiotic active against aerobic&nbsp; bacteria</p><p>The treatment of severe intra-abdominal and gynaecological infections in which sensitive anaerobic bacteria particularly</p><p>&nbsp;</p><p>Bacteriodes and anaerobic Streptococci have been identified or are suspected to be the cause<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-indent:50px">Metronidazole 500mg/100ml Intravenous Infusion should be infused intravenously at an approximate rate of 5 ml/minute (or one bag infused over 20 to 60 minutes). Oral medication should be substituted as soon as feasible<br />&nbsp;</p><p style="text-indent:50px"><strong>:Prophylaxis against postoperative infections caused by anaerobic bacteria</strong></p><p style="text-indent:50px">Primarily in the context of abdominal, (especially colorectal) and gynaecological surgery.<br />Antibiotic prophylaxis duration should be short, mostly limited to the post-operative period (24 hours but never more than 48 hours). Various schedules are possible.Adults: Intra-venous injection of single dose of 1000mg-1500mg, 30-60 minutes preoperatively or alternatively 500mg immediately before, during or after operation, then 500mg 8 hourly</p><p style="text-indent:50px">Children &lt; 12 years: 20-30 mg/kg as a single dose given 1-2 hours before surgery.</p><p style="text-indent:50px">Newborns with a gestation age &lt;40 weeks: 10 mg/kg body weight as a single dose before operation</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px"><strong>:Anaerobic infections</strong></p><p style="text-indent:50px">Intravenous route is to be used initially if patient symptoms preclude oral therapy. Various schedules are possible</p><p style="text-indent:50px">Adults: 1000mg &ndash; 1500mg daily as a single dose or alternatively 500mg every 8 hours.</p><p style="text-indent:50px"><br />Children &gt; 8 weeks to 12 years of age: The usual daily dose is 20-30mg/kg/day as a single dose or divided into 7.5 mg/kg every 8 hours. The daily dose may be increased to 40 mg/kg, depending on the severity of the infection. Duration of treatment is usually 7 days</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px">Children &lt; 8 weeks of age: 15 mg/kg as a single dose daily or divided into 7.5 mg/kg every 12 hours</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px">In newborns with a gestation age &lt; 40 weeks, accumulation of metronidazole can occur during the first week of life, therefore the concentrations of metronidazole in serum should preferably be monitored after a few days of therapy</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px">Oral medication could be given, at the same dose regimen. Oral medication should be substituted as soon as feasible</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px"><strong>Duration of Treatment</strong></p><p style="text-indent:50px">Treatment for seven to ten days should be satisfactory for most patients but, depending upon clinical and bacteriological assessments, the physician might decide to prolong treatment e.g.; for the eradication of infection from sites which cannot be drained or are liable to endogenous recontamination by anaerobic pathogens from the gut, oropharynx or genital tract</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px"><strong>:Bacterial vaginosis</strong></p><p style="text-indent:50px">Adolescents: 400 mg twice daily for 5-7 days or 2000 mg as a single dose</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px"><strong>:Urogenital trichomoniasis</strong></p><p style="text-indent:50px">Adults and adolescents: 2000 mg as a single dose or 200 mg 3 times daily for 7 days or 400 mg twice daily for 5-7 days.</p><p style="text-indent:50px">Children &lt; 10 years: 40 mg/kg orally as a single dose or 15 &ndash; 30 mg/kg/day divided in 2-&nbsp;3 doses for 7 days; not to exceed 2000 mg/dose</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px"><strong>:Giardiasis</strong></p><p style="text-indent:50px">more than 10 years: 2000 mg once daily for 3 days, or 400 mg three times daily for 5 days, or 500 mg twice daily for 7 to 10 days</p><p style="text-indent:50px">Children 7 to 10 years: 1000 mg once daily for 3 days<br />Children 3 to 7 years: 600 to 800 mg once daily for 3 days<br />Children 1 to 3 years: 500 mg once daily for 3 days</p><p style="text-indent:50px">Alternatively, as expressed in mg per kg of body weight: 15-40 mg/kg/day divided in 2-3 doses</p><p style="text-indent:50px"><strong>Amoebiasis</strong><br />more than 10&nbsp; years: 400 to 800 mg 3 times daily for 5-10 days</p><p style="text-indent:50px">Children 7 to 10 years: 200 to 400 mg 3 times daily for 5-10 days</p><p style="text-indent:50px">Children 3 to 7 years: 100 to 200 mg 4 times daily for 5-10 days</p><p style="text-indent:50px">Children 1 to 3 years: 100 to 200 mg 3 times daily for 5-10 days</p><p style="text-indent:50px">Alternatively, doses may be expressed by body weight 35 to 50 mg/kg daily in 3 divided doses for 5 to 10 days, not to exceed 2400 mg/day</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px"><strong>Eradication of helicobacter pylori in paediatric patients</strong></p><p style="text-indent:50px">As a part of a combination therapy, 20 mg/kg/day not to exceed 500 mg twice daily for 7- 14 days</p><p style="text-indent:50px">Official guidelines should be consulted before initiating therapy<br /><br /><strong>Elderly population</strong><br /><br />&nbsp;.Caution is advised in the elderly, particularly at high doses, although there is limited&nbsp; information available on modification of dosage</p><p style="text-indent:50px"><strong>Patients with renal failure</strong><br /><br />.Routine adjustments of the dosage of Metronidazole are not considered necessary in the presence of renal failure&nbsp;No routine adjustment in the dosage of Metronidazole needs to be made in patients with renal failure undergoing intermittent peritoneal dialysis (IDP) or continuous ambulatory peritoneal dialysis (CAPD). However dosage reduction may be necessary when excessive concentrations of metabolites are found</p><p style="text-indent:50px">&nbsp;</p><p style="text-indent:50px">In patients undergoing haemodialysis, Metronidazole should be re-administered&nbsp; immediately after haemodialysis</p><p style="text-indent:50px"><strong>Patients with advanced hepatic insufficiency</strong><br />&nbsp;</p><p style="text-indent:50px">In patients with advanced hepatic insufficiency a dosage reduction with serum level monitoring is necessary</p><p style="text-indent:50px"><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to other imidazole derivatives or to any of the  excipient 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Caution is needed in patients with severe hepatic impairment. The dose of metronidazole should be reduced as necessary. Metronidazole is mainly metabolized by hepatic oxidation. Substantial impairment of Metronidazole clearance may occur in the presence of advanced hepatic insufficiency. The risk/benefit ratio of using Metronidazole to treat trichomoniasis in such&nbsp; patients should be carefully considered (for dosage adjustment see section 4.2). Plasma levels of Metronidazole should be closely monitored</p><p>Caution is needed in patients with hepatic encephalopathy. Patients with severe hepatic encephalopathy metabolize metronidazole slowly, with resultant accumulation of metronidazole. This&nbsp; may cause exacerbation of CNS adverse effects. The dose of metronidazole should be reduced as necessary</p><p>Cases of severe hepatotoxicity/acute hepatic failure, including cases with a fatal outcome with very rapid onset after treatment initiation in patients with Cockayne syndrome have been&nbsp; reported with products containing metronidazole for systemic use<br />In this population, metronidazole should therefore be used after careful benefit-risk assessment and only if no alternative treatment is available. Liver function tests must be performed just prior to the start of therapy, throughout and after end of treatment until liver function is within normal ranges, or until the baseline values are reached. If the liver function tests become markedly elevated during treatment, the drug should be discontinued<br />&nbsp;</p><p>Patients with Cockayne syndrome should be advised to immediately report any symptoms of potential liver injury to their physician and stop taking metronidazole-&nbsp;</p><p><strong>:Active central nervous system disease</strong></p><p>&nbsp;.Metronidazole should be used with caution in patients with active disease of the Peripheral and Central Nervous System Severe neurological disturbances (including seizures and peripheral and optic neuropathies) have been reported in patients treated with metronidazole. Stop metronidazole treatment if any abnormal neurologic symptoms occur such as ataxia, dizziness, confusion or any other CNS adverse reaction. The risk of aggravation of the neurological state should be considered in patients with fixed or progressive paraesthesia, epilepsy and active disease of the central nervous system except for brain abscess<br /><br />Encephalopathy has been reported in association with cerebellar toxicity characterized by ataxia, dizziness, dysarthria, and accompanied by CNS lesions seen on magnetic resonance imaging</p><p>(MRI). CNS symptoms and CNS lesions, are generally reversible within days to weeks upon discontinuation of metronidazole</p><p>&nbsp;</p><p>Aseptic meningitis can occur with metronidazole. Symptoms can start within hours of dose administration and generally resolve after metronidazole therapy is discontinued<br />&nbsp;</p><p><strong>Blood dyscrasis</strong><br /><br />Metronidazole should be used with caution in patients with evidence or history of blood dyscrasia as agranulocytosis, leukopenia and neutropenia have been observed following metronidazole administration</p><p><strong>:Renal disease</strong></p><p>.Metronidazole is removed during haemodialysis and should be administered after the procedure is finished</p><p>.Patients with renal impairment, including patients receiving peritoneal dialysis, should be monitored for signs of toxicity due to the potential accumulation of toxic metronidazole metabolites</p><p><strong>:Sodium restricted patients</strong></p><p>This medicinal product contains 13.5 mmol (310 mg) sodium per 100 mL. To be taken into consideration by patients on a controlled sodium die</p><p><strong>Alcohol</strong><br />Patients should be advised to discontinue consumption of alcoholic beverages or alcoholcontaining products before, during, and up to 72 hours after taking metronidazole because of a&nbsp; disulfram-like effect (abdominal cramps, nausea, headaches, flushing, vomiting and tachycardia)</p><p><br /><strong>Intensive or prolonged metronidazole therapy</strong><br /><br />As a rule, the usual duration of therapy with i.v Metronidazole or other imidazole derivatives is usually less than 10 days<br /><br />.As a rule, the usual duration of therapy with i.v Metronidazole or other imidazole derivatives is usually less than 10 days</p><p>Intensive or prolonged Metronidazole therapy should be conducted only under conditions of close surveillance for clinical and biological effects and under specialist direction. If prolonged therapy is required, the physician should bear in mind the possibility of peripheral neuropathy or leucopenia. Both effects are usually reversible</p><p>In case of prolonged treatment, occurrence of undesirable effects such as paraesthesia, ataxia, dizziness and convulsive crises should be checked. High dose regimes have been associated with transient epileptiform seizures.</p><p>&nbsp;</p><p><strong>Monitoring</strong></p><p>Due to increased risk for adverse reactions, regular clinical and laboratory monitoring (including blood count) are advised in cases of high-dose, prolonged or repeatedtreatment, in case of antecedents of blood dyscrasia, in case of severe infection and insevere hepatic insufficiency</p><p>&nbsp;</p><p><strong>General</strong><br />(Patients should be warned that Metronidazole may darken urine (due to Metronidazole metabolite</p><p><br /><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Not recommended concomitant therapy</strong><br />Disulfiram: Concurrent use of metronidazole and disulfiram may result in psychotic reactions and confusion.<br />Metronidazole should not be given to patients who have taken disulfiram within the last two weeks</p><p>(Alcohol: Disulfiram-like effect (warmth, redness, vomiting, tachycardia</p><p>Alcohol beverage and drugs containing alcohol should be avoided. Patients should be advised not to take alcohol during</p><p>Alcohol beverage and drugs containing alcohol should be avoided. Patients should be advised not to take alcohol during</p><p><br /><strong>Concomitant therapy requiring special precautions</strong><br />Oral anticoagulants (warfarin): metronidazole may increase the anticoagulant effects of warfarin and other oral anticoagulants, resulting in a prolongation of the prothrombin time and increased risk of haemorrhage (decrease in its liver catabolism). Patients taking metronidazole and warfarin or other oral coumarins concomitantly should have their prothrombin time and international normalized ratio (INR) monitored more frequently. Patients should be monitored for signs and symptoms of bleeding</p><p>A large number of patients have been reported showing an increase in oral anticoagulant activity whilst receiving concomitant antibiotic therapy. The infectious and inflammatory status of the patient, together with their age and general well-being are all risk factors in this context. However, in these circumstances it is not clear as to the part played by the disease itself or its treatment in the occurrence of prothrombin time disorders. Some classes of antibiotics are more likely to result in this interaction, notably fluoroquinolones, macrolides, cyclines, cotrimoxazole and some cephalosporins</p><p>Vecuronium (non depolarising curaremimetic): Metronidazole can potentialise the effects of vecuronium</p><p><strong>Combination to be considered</strong></p><p>5 Fluoro-uracile: increase in the toxicity of 5 fluoro-uracile due to a decrease of its clearance Lithium: lithium retention accompanied by evidence of possible renal damage has been reported in patients treated simultaneously with lithium and Metronidazole. Lithium treatment should be tapered or withdrawn before administering</p><p>Lithium: lithium retention accompanied by evidence of possible renal damage has been reported in patients treated simultaneously with lithium and Metronidazole. Lithium treatment should be tapered or withdrawn before administering</p><p><br />Cholestyramine may delay or reduce the absorption of Metronidazole</p><p>Phenytoin, barbiturates (phenobarbital): concomitant administration of drugs that induce microsomal liver enzyme activity, such as phenytoin or phenobarbital, may accelerate the elimination of metronidazole and therefore decrease its efficacy. Cimetidine: concomitant administration of drugs that decrease microsomal liver enzyme activity, such as cimetidine, may cause decreased metabolism and reduced plasma clearance of metronidazole which may result in metronidazole toxicity</p><p>&nbsp;</p><p>Phenytoin, barbiturates (phenobarbital): concomitant administration of drugs that induce microsomal liver enzyme activity, such as phenytoin or phenobarbital, may accelerate the elimination of metronidazole and therefore decrease its efficacy. Cimetidine: concomitant administration of drugs that decrease microsomal liver enzyme activity, such as cimetidine, may cause decreased metabolism and reduced plasma clearance of metronidazole which may result in metronidazole toxicity</p><p>Busulfan: Plasma concentrations of busulfan may increase during concomitant treatment with metronidazole, which can result in serious busulfan toxicity such as sinusoidal obstruction syndrome, gastrointestinal mucositis, and hepatic Veno-occlusive disease</p><p><strong>Laboratory tests</strong></p><p>Metronidazole may immobilise Treponema and thus may lead to falsely positive Nelson&#39;s test</p><p>&nbsp;</p><p>Metronidazole may interfere with serum aspartate transaminase (AST), alanine transaminase (ALT), lactate dehydrogenase (LDH), triglycerides, and glucose hexokinase determinations. Metronidazole causes an increase in ultraviolet absorbance at 340 nm resulting in falsely decreased values</p><p><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p style="text-indent:50px"><strong>Pregnancy</strong></p><p style="text-indent:50px">Metronidazole crosses the placental barrier</p><p style="text-indent:50px">Clinical data on a large number of exposed pregnancies and animal data did not show a teratogenic or foetotoxic effect</p><p style="text-indent:50px">However unrestricted administration of nitroimidazolene to the mother may be associated with a carcinogenic or mutagenic risk for the unborn or newborn child</p><p style="text-indent:50px">Therefore Metronidazole should not be given during pregnancy unless clearly necessary<br />&nbsp;</p><p style="text-indent:50px"><strong>Lactation</strong></p><p style="text-indent:50px">Metronidazole is excreted in breast milk. During lactation either breast-feeding or Metronidazole should be discontinued</p><p style="text-indent:50px"><strong>Fertility</strong></p><p style="text-indent:50px">There are no clinical data relating to the effect of metronidazole on fertility<br />Animal studies demonstrated adverse effects on the male reproductive system that are wholly or partially reversible after treatment withdrawal<br /><br /><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies have been performed following intravenous treatment with Metronidazole on the ability to drive and use machines. Some adverse reactions to metronidazole such as seizure, dizziness, optic neuropathy, may impair the ability to drive or operate machines<br />&nbsp;</p><p>Therefore it is recommended that patients should not drive or use machines.<br /><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no data available on adverse reactions from Baxter-sponsored clinical trials conducted with Metronidazole.</p><p>(The following adverse reactions have been reported with Metronidazole, listed by MedDRA System Organ Class (SOC</p><p><br />Preferred Term and frequency. The following frequency groupings are used: very&nbsp;common (&ge;1/10); common (&ge;1/100 and &lt;1/10); uncommon (&ge;1/1,000 and &lt;1/100); rare (&ge;1/10,000 and &lt;1/1,000); very rare (&lt;1/10,000) and not known (cannot be estimated from the available data</p><p>Frequency, type and severity of adverse reactions in children are the same as in adult</p><table border="1" cellspacing="0" cellpadding="0" style="width:669px"><tbody><tr><td><p dir="LTR"><strong>System Organ Class (SOC) </strong></p></td><td><p dir="LTR"><strong>Preferred MedDRA Term </strong></p></td><td><p dir="LTR"><strong>Frequency</strong></p></td></tr><tr><td><p dir="LTR">Blood and Lymphatic System<br />Disorders</p></td><td><p dir="LTR">Leukopenia<br />Agranulocytosis<br />Pancytopenia<br />Neutropenia<br />Thrombocytopenia<br />Eosinophilia</p></td><td><p dir="LTR">uncommon<br />rare<br />rare<br />rare<br />rare<br />not known</p></td></tr><tr><td><p dir="LTR">Immune System Disorder</p></td><td><p dir="LTR">Anaphylactic shock<br />Jarisch-Herxheimer reaction Hypersensitivity</p></td><td><p dir="LTR">rare<br />rare<br />not known</p></td></tr><tr><td><p dir="LTR">Metabolism and Nutrition</p></td><td><p dir="LTR">Decreased appetite</p></td><td><p dir="LTR">not known</p></td></tr><tr><td><p dir="LTR"><br />Psychiatric Disorders</p></td><td><p dir="LTR">Hallucinations<br />Depression<br />Confusional state<br />Insomnia</p></td><td><p dir="LTR">rare<br />not known<br />not known<br />not known</p></td></tr><tr><td><p dir="LTR">Nervous System Disorders</p></td><td><p dir="LTR">Dysgeusia<br />Headache<br />Encephalopaty<br />Meningitis aseptc<br />Seizure<br />Somnolence<br />Neuropathy peripherl<br />Ataxia<br />DizzinessDysartha<br />Hypoaesthesia<br />Paraesthesia</p></td><td><p dir="LTR">common<br />uncommon<br />rare<br />rare<br />rare<br />rare<br />rare<br />rare<br />rare<br />not known<br />not known<br />not known</p></td></tr><tr><td><p dir="LTR">Eye Disorders</p></td><td><p dir="LTR">Opticneuropathy<br />Diplopia<br />Myopia</p></td><td><p dir="LTR">rare<br />rare<br />rare</p></td></tr><tr><td><p dir="LTR">System Organ Class (SOC)</p></td><td><p dir="LTR">Preferred MedDRA Term</p></td><td><p dir="LTR">Frequency</p></td></tr><tr><td><p dir="LTR">Blood and Lymphatic System<br />Disorders</p></td><td><p dir="LTR">Leukopenia<br />Agranulocytosis<br />Pancytopenia<br />Neutropenia<br />Thrombocytopenia<br />Eosinophilia</p></td><td><p dir="LTR">uncommon<br />rare<br />rare<br />rare<br />rare<br />not known</p></td></tr><tr><td><p dir="LTR">Immune System Disorder</p></td><td><p dir="LTR">Anaphylactic shock<br />Jarisch-Herxheimer reaction Hypersensitivity</p></td><td><p dir="LTR">rare<br />rare<br />not known</p></td></tr><tr><td><p dir="LTR">Metabolism and Nutrition</p></td><td><p dir="LTR">Decreased appetite</p></td><td><p dir="LTR">not known</p></td></tr><tr><td><p dir="LTR"><br />Psychiatric Disorders</p></td><td><p dir="LTR">Hallucinations<br />Depression<br />Confusional state<br />Insomnia</p></td><td><p dir="LTR">rare<br />not known<br />not known<br />not known</p></td></tr><tr><td><p dir="LTR">Nervous System Disorders</p></td><td><p dir="LTR">Dysgeusia<br />Headache<br />Encephalopaty<br />Meningitis aseptc<br />Seizure<br />Somnolence<br />Neuropathy peripherl<br />Ataxia<br />DizzinessDysartha<br />Hypoaesthesia<br />Paraesthesia</p></td><td><p dir="LTR">common<br />uncommon<br />rare<br />rare<br />rare<br />rare<br />rare<br />rare<br />rare<br />not known<br />not known<br />not known</p></td></tr><tr><td><p dir="LTR">Eye Disorders</p></td><td><p dir="LTR">Opticneuropathy<br />Diplopia<br />Myopia</p></td><td><p dir="LTR">rare<br />rare<br />rare</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><table border="1" cellspacing="0" cellpadding="0" style="width:696px"><tbody><tr><td><p dir="LTR">Cardiac Disorders</p></td><td><p dir="LTR">Tachycardia<br />Palpitations</p></td><td><p dir="LTR">Not known<br />not known</p></td></tr><tr><td><p dir="LTR">Respiratory, Thoracic and<br />Mediastinal Disorders</p></td><td><p dir="LTR">Dyspnoea</p></td><td><p dir="LTR">not known</p></td></tr><tr><td><p dir="LTR">Gastrointestinal Disorders</p></td><td><p dir="LTR">Glossitis<br />Stomatitis<br />Dry mouth Pancreatitis<br />Abdominal pain upper<br />Diarrhoea<br />Nausea<br />Vomiting<br />Constipation<br />Tongue discoloration</p></td><td><p dir="LTR">common<br />common<br />common<br />rare<br />rare<br />rare<br />rare<br />rare<br />not known<br />not known</p></td></tr><tr><td><p dir="LTR">Hepatobiliary disorders</p></td><td><p dir="LTR">Jaundice cholestatic</p></td><td><p dir="LTR">rare</p></td></tr><tr><td><p dir="LTR">Skin and Subcutaneous Disorders</p></td><td><p dir="LTR">Stevens-Johnson syndrome<br />Toxic epidermal necrolysis<br />Angioedema<br />Erythema multiforme<br />Pruritus<br />Swelling face<br />Urticaria<br />Hyperhidrosis<br />Rash</p></td><td><p dir="LTR">rare<br />rare<br />rare<br />rare<br />not known<br />not known<br />not known<br />not known<br />not known</p></td></tr><tr><td><p dir="LTR">Musculoskeletal and<br />Connective Tissue Disorders</p></td><td><p dir="LTR">Myalgia<br />Muscle spasms<br />Arthralgia</p></td><td><p dir="LTR">common<br />not known<br />not known</p></td></tr><tr><td><p dir="LTR">Renal and urinary disorders</p></td><td><p dir="LTR">Chromaturia<br />Dysuria</p></td><td><p dir="LTR">rare<br />not known</p></td></tr><tr><td><p dir="LTR">General and Administration Site<br />Conditions</p></td><td><p dir="LTR">Asthenia<br />Mucosal inflammation<br />Pyrexia<br />Injection site reaction<br />Malaise<br />Face oedema<br />Oedema peripheral<br />Chest pain<br />Chills</p></td><td><p dir="LTR">uncommon<br />rare<br />rare<br />not known<br />not known<br />not known<br />not known<br />not known<br />not known</p></td></tr><tr><td><p dir="LTR">Investigations</p></td><td><p dir="LTR">Hepatic enzyme increased</p></td><td><p dir="LTR">not known</p></td></tr></tbody></table><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p dir="RTL">Symptoms<br />In cases of overdose in adults, the clinical symptoms are usually limited to nausea,<br />vomiting and neurotoxic effects, including ataxia, slight disorientation, confusion,<br />seizures and peripheral neuropathy</p><p dir="RTL">&nbsp;</p><p dir="RTL">Treatment<br />There is no specific treatment for Metronidazole overdose, Metronidazole infusion should be discontinued. Patients should be treated symptomatically</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of<br />nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is<br />probably caused by interaction with DNS and different metabolites.<br />Pharmacotherapeutic group: Antibacterials for systemic use: imidazole derivatives<br />ATC Code: J01XD01 and<br />Pharmacotherapeutic group: Antiprotozoals: nitroimidazole derivatives<br />ATC Code: P01AB01.<br />Metronidazole has antibacterial and antiprotozoal actions and is effective against<br />anaerobic bacteria and against Trichomonas vaginalis and other protozoa including<br />Entamoeba histolytica and Giardia lamblia.<br />Anti-microbial spectrum<br />The MIC breakpoints separating susceptible from intermediately susceptible and<br />intermediately susceptible from resistant organisms are as following:<br />S &le; 4 mg/l and R &gt; 4 mg/l<br />The prevalence of acquired resistance may vary geographically and with time for selected<br />species and local information is desirable, particularly when treating severe infections.<br />This information gives only approximate guidance on probabilities whether<br />microorganisms will be susceptible to Metronidazole or not<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Distribution: After administration of a single 500 mg dose, mean Metronidazole peak<br />plasma concentrations of ca. 14 &ndash; 18 &mu;g/ml are reached at the end of a 20 minute<br />infusion. 2-hydroxy-metabolite peak plasma concentrations of ca. 3&mu;g/ml are obtained<br />after a 1 g single i.v. dose. Steady state Metronidazole plasma concentrations of about 17<br />and 13&mu;g/ml are reached after administration of Metronidazole every 8 or 12 hours,<br />respectively.<br />Plasma protein binding is less than 10%, and the volume of distribution 1.1 &plusmn; 0.4 l/kg.<br />Metabolism: Metronidazole is metabolized in the liver by hydroxylation, oxidation and<br />glucuronidation. The major metabolites are a 2-hydroxy- and an acetic acid metabolite.<br />Elimination: More than 50% of the administered dose is excreted in the urine, as<br />unchanged Metronidazole (ca. 20% of the dose) and its metabolites. About 20% of the<br />dose is excreted with faeces. Clearance is 1.3 &plusmn; 0.3 ml/min/kg, while renal clearance is<br />about 0.15 ml/min/kg. The plasma elimination half-life of Metronidazole is ca. 8 hours,<br />and of the 2-hydroxy-metabolite ca. 10 hours.<br />Special patient groups: The plasma elimination half-life of Metronidazole is not<br />influenced by renal impairment, however this may be increased for 2-hydroxy- and an<br />acetic acid metabolite. In the case of haemodialysis, Metronidazole is rapidly excreted<br />and the plasma elimination half-life is decreased to ca. 2.5 h. Peritoneal dialysis does not<br />appear to affect the elimination of Metronidazole or its metabolites compared to patients<br />with renal impairment<br />In patients with impaired liver function, the metabolism of Metronidazole is expected to<br />decrease, leading to an increase in the plasma elimination half-life. In patients with<br />severe liver impairment, clearance may be decreased up to ca. 65%, resulting in an<br />accumulation of Metronidazole in the body<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Metronidazole has been shown to be non-mutagenic in mammalian cells in vitro and in<br />vivo.<br />Metronidazole and a metabolite have been shown to be mutagenic is some tests with nonmammalian cells<br />Although Metronidazole has been shown to be carcinogenic in certain species of mice, it<br />was not carcinogenic in either rats or guinea pigs. There is no suspicion of<br />carcinogenicity in man.<br />Daily per oral metronidazole at 5-times the maximum human daily dose for greater than 4<br />weeks caused testicular toxicity and infertility in male rats. Fertility was restored in most<br />subjects by 8 weeks after cessation of treatment, whereas the lower testicular and<br />epididymal weights and sperm counts had improved but were still observed<br />&nbsp;</p><p>Daily per oral metronidazole at approximately 6-times the maximum human daily dose<br />for &ge;2 weeks caused testicular toxicity in male mice. Most indices of testicular toxicity<br />were restored within 2 months after cessation of treatment, whereas the lower testicular<br />and epididymal weights had improved but were still observed.<br />These studies demonstrate that the adverse effects of metronidazole on the male<br />reproductive system are wholly or partially reversible after treatment withdrawal<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sodium phosphate dibasic anhydrous<br />Citric acid<br />Sodium chloride<br />Water for injection<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not use equipment containing aluminum (e.g., needles, cannulae) that would come in<br />contact with the drug solution as precipitates may form.<br />Metronidazole is incompatible with (includes but is not limited to):<br />- Aztreonam<br />- Cefamandole nafate<br />- Cefoxitin<br />- Penicillin G<br />In the absence of compatibility studies, this medicinal product must not be mixed with<br />other medicinal product<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                In the absence of compatibility studies, this medicinal product must not be mixed with
other medicinal product 
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Store below 30&deg;C, protect from light<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carton box containing transparent colorless (type II) glass vial containing 100 ml solution<br />sealed with bromobutyl rubber bungs with AL over-caps covered with polypropylene<br />plastic flip off seal disc + inner leaflet.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Use only if the solution is clear, without visible particles and if the container is<br />undamaged. Administer immediately following the insertion of infusion set.<br />Do not remove unit from overpouch until ready for use.<br />The inner bag maintains the sterility of the product.<br />Do not use plastic containers in series connections. Such use could result in air embolism<br />due to residual air being drawn from the primary container before the administration of<br />the fluid from the secondary container is completed.<br />Pressurizing intravenous solutions contained in flexible plastic containers to increase<br />flow rates can result in air embolism if the residual air in the container is not fully<br />evacuated prior to administration.<br />Use of a vented intravenous administration set with the vent in the open position could<br />result in air embolism. Vented intravenous administration sets with the vent in the open<br />position should not be used with flexible plastic containers.<br />The solution should be administered with sterile equipment using an aseptic technique.<br />The equipment should be primed with the solution in order to prevent air entering the<br />system.<br />In patients maintained on intravenous fluids, Metronidazole 500mg/100ml Intravenous<br />Infusion may be diluted with appropriate volumes of 0.9% sodium chloride solution,<br />dextrose 5% - 0.9% sodium chloride solution, dextrose 5% w/v or potassium chloride<br />infusions (20 and 40 mmol/litre).<br />Using an incorrect administration technique might cause the appearance of fever<br />reactions due to the possible introduction of pyrogens. In the case of adverse reaction,<br />infusion must be stopped immediately.<br />Additives:<br />Additives known or determined to be incompatible should not be used.<br />Before adding a substance or medication, verify that it is soluble and stable in<br />metronidazole, and that the pH range of metronidazole is appropriate. Additives may be<br />incompatible. When introducing additives, the instructions for use of the medication to be<br />added and other relevant literature must be consulted (see Section 6.2).<br />Mix the solution thoroughly when additives have been introduced<br />Use only if the solution is clear, without visible particles and if the container is<br />undamaged. Administer immediately following the insertion of infusion set.<br />Do not remove unit from overpouch until ready for use.<br />The inner bag maintains the sterility of the product.<br />Do not use plastic containers in series connections. Such use could result in air embolism<br />due to residual air being drawn from the primary container before the administration of<br />the fluid from the secondary container is completed.<br />Pressurizing intravenous solutions contained in flexible plastic containers to increase<br />flow rates can result in air embolism if the residual air in the container is not fully<br />evacuated prior to administration.<br />Use of a vented intravenous administration set with the vent in the open position could<br />result in air embolism. Vented intravenous administration sets with the vent in the open<br />position should not be used with flexible plastic containers.<br />The solution should be administered with sterile equipment using an aseptic technique.<br />The equipment should be primed with the solution in order to prevent air entering the<br />system.<br />In patients maintained on intravenous fluids, Metronidazole 500mg/100ml Intravenous<br />Infusion may be diluted with appropriate volumes of 0.9% sodium chloride solution,<br />dextrose 5% - 0.9% sodium chloride solution, dextrose 5% w/v or potassium chloride<br />infusions (20 and 40 mmol/litre).<br />Using an incorrect administration technique might cause the appearance of fever<br />reactions due to the possible introduction of pyrogens. In the case of adverse reaction,<br />infusion must be stopped immediately.<br />Additives:<br />Additives known or determined to be incompatible should not be used.<br />Before adding a substance or medication, verify that it is soluble and stable in<br />metronidazole, and that the pH range of metronidazole is appropriate. Additives may be<br />incompatible. When introducing additives, the instructions for use of the medication to be<br />added and other relevant literature must be consulted (see Section 6.2).<br />Mix the solution thoroughly when additives have been introduced<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amriya for Pharmaceutical Industries.
Amriya, Alexandria-Cairo Desert Road, Km 25, Alexandria-Egypt
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                March 2019
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>